Clovis Oncology

- NASDAQ:CLVS
Last Updated 2024-03-26
  • Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
  • Locations

    • Boulder CO
  • Total Funding (USD)

    145.0 million
  • Industries

    Internet, Cyber Security
  • Security

    Type: ORD
    CUSIP: 189464100
    ISIN: US1894641000
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo.old 2019-09-24
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.